Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Vannucchi, A.
2404  Ergebnisse:
Personensuche X
?
1

CONVOLUTIONAL NEURAL NETWORKS AS MODEL OBSERVERS FOR COMPUT..:

Doria, S. ; Bartolucci, M. ; Cantoni, E....
Physica Medica.  115 (2023)  - p. 102842 , 2023
Link: https://doi.org/10.1016/..
 
?
2

P22 THE PROGNOSTIC ROLE OF 1Q ABNORMALITIES IN NEWLY DIAGNO..:

Attucci, I. ; Pilerci, S. ; Bonifacio, S....
HemaSphere.  7 (2023)  S2 - p. 22-22 , 2023
Link: https://doi.org/10.1097/..
 
?
3

P48 CARFILZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED..:

Attucci, I. ; Antonioli, E. ; Pilerci, S....
HemaSphere.  7 (2023)  S2 - p. 37-37 , 2023
Link: https://doi.org/10.1097/..
 
?
4

S198: BET INHIBITOR PELABRESIB (CPI-0610) COMBINED WITH RUX..:

Mascarenhas, J. ; Kremyanskaya, M. ; Patriarca, A....
HemaSphere.  6 (2022)  - p. 99-100 , 2022
Link: https://doi.org/10.1097/..
 
?
5

P1041: IMPACT OF FEDRATINIB ON SPLEEN VOLUME AND MYELOFIBRO..:

Kiladjian, J.-J. ; Tefferi, A. ; Passamonti, F....
HemaSphere.  6 (2022)  - p. 931-932 , 2022
Link: https://doi.org/10.1097/..
 
?
6

P1068: RISK-ADJUSTED SAFETY ANALYSIS OF PACRITINIB IN PATIE..:

Vannucchi, A. ; Pemmaraju, N. ; Scott, B....
HemaSphere.  6 (2022)  - p. 958-959 , 2022
Link: https://doi.org/10.1097/..
 
?
7

P1033: A PHASE 2 STUDY OF THE LSD1 INHIBITOR IMG-7289 (BOME..:

Palandri, F. ; Ross, D. M. ; Cochrane, T....
HemaSphere.  6 (2022)  - p. 923-924 , 2022
Link: https://doi.org/10.1097/..
 
?
8

P1050: THROMBOCYTOPENIC MYELOFIBROSIS (MF) PATIENTS PREVIOU..:

Vannucchi, A. ; Mesa, R. ; Gerds, A....
HemaSphere.  6 (2022)  - p. 940-941 , 2022
Link: https://doi.org/10.1097/..
 
?
9

P1030: MANIFEST-2, A GLOBAL, PHASE 3, RANDOMIZED, DOUBLE-BL..:

Harrison, C. ; Rampal, R. K. ; Gupta, V....
HemaSphere.  6 (2022)  - p. 920-921 , 2022
Link: https://doi.org/10.1097/..
 
?
10

S195: MOMENTUM: PHASE 3 RANDOMIZED STUDY OF MOMELOTINIB (MM..:

Verstovsek, S. ; Vannucchi, A. ; Gerds, A....
HemaSphere.  6 (2022)  - p. 96-97 , 2022
Link: https://doi.org/10.1097/..
 
?
11

P1029: MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC) OF PELA..:

Gupta, V. ; Mascarenhas, J. ; Kremyanskaya, M....
HemaSphere.  6 (2022)  - p. 919-920 , 2022
Link: https://doi.org/10.1097/..
 
?
12

P1069: RETROSPECTIVE COMPARISON OF PATIENT OUTCOMES ON PACR..:

Harrison, C. ; Bose, P. ; Mesa, R....
HemaSphere.  6 (2022)  - p. 959-960 , 2022
Link: https://doi.org/10.1097/..
 
?
13

Diagnostic role of internal mammary lymph node involvement ..:

Levi, G. ; Rocchetti, C. ; Mei, F....
Pulmonology.  , 2022
Link: https://doi.org/10.1016/..
 
?
14

Which patients with myelofibrosis should receive ruxolitini..:

Marchetti, M ; Barosi, G ; Cervantes, F...
Leukemia.  31 (2016)  4 - p. 882-888 , 2016
Link: https://doi.org/10.1038/..
 
?
15

51. Effects of a short physical therapy program combined wi..:

Borgheresi, A. ; Giovannelli, F. ; Cozzi, S....
Clinical Neurophysiology.  124 (2013)  11 - p. e200 , 2013
Link: https://doi.org/10.1016/..
 
1-15